Release Date: 16/08/18 11:01 Summary: Initial Director's Interest Notice Price Sensitive: No Download Document 110.62KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%